Clinical trial
ORCA Study: Osteoarthritis and Risks Associated With the Consumption of NSAIDs
NCT04099459 is registered in ClinicalTrials.gov with Scandinavia Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ORCA Study: Osteoarthritis and Risks Associated With the Consumption of NSAIDs
- Lead sponsor
- Scandinavia Pharma
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 10, 2019
- Completion date
- July 31, 2024
- Enrollment
- 1,250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.